The U.S. Centers for Disease Control and Prevention have recommended the first-ever vaccine designed to protect infants from respiratory syncytial virus. The CDC said the Pfizer vaccine should be taken during weeks 32 and 36 of pregnancy.Sept 23, 2023 ...
The Centers for Disease Control and Prevention (CDC) updated its RSV vaccine guidance for seniors for this upcoming respiratory viral season, saying the new recommendations are meant to simplify decision-making for patients and clinicians. The new guidan
older, according to a recent CDC statement. The vaccines should be administered using shared clinical decision-making, meaning individuals can receive a single dose of the vaccine based on conversations with their health care provider about whether RSV vaccination is the best course of action for ...
"We know from the start that this vaccine has durability, which is important versus the COVID vaccine, [which] can lose efficacy after four to six months, reducing public confidence in the vaccine," Dr. Dan Barouch, director of the Center for Virology and Vaccine Research at...
Vaccine makers are still studying when seniors might need to come back for a booster dose of RSV vaccine in the coming years. They also have yet to decide on a final price, further complicating broader recommendations. GSK said their vaccine could be priced between $200 and $295 per dose,...
Originally, Arexvy was the only FDA-approved RSV vaccine for older adults. However, since this approval, two other RSV vaccines have come to market. The Pfizer RSV vaccine, Abrysvo, is also a protein subunit vaccine. The CDC estimates the effectiveness of protein subunit RS...
The company's single-dose vaccine is the first RSV treatment to use maternal immunization: Expectant mothers get vaccinated with the shot, which triggers antibodies that are passed to the fetus. That provides infants with protection against the virus from birth through the first six months of ...
The CDC has recommended Pfizer's maternal RSVpreF vaccine (Abrysvo) to protect newborns from severe respiratory syncytial virus (RSV) illness, according to a news release. Approved by the FDA in August 2023, the vaccine has been shown to reduce the risk of RSV hospitalization by 57% for ...
CDC to meet on FDA-approved RSV vaccine, local mother details twins' health scare last fall BySarah Schulte Thursday, August 3, 2023RSV is the leading cause of hospitalization in infants under a year old in the United States every year. A local mother detailed her first-hand experience.CHICA...
COVID-19 cases rise in North Texas as FDA authorizes updated vaccine The XBB 1.5 variant is one of the most dominant variants we're seeing locally. Sep 11, 2023 FDA approves new drug to prevent RSV in children Fall flu and virus season is right around the corner, but this year, a new...